Cerebro-oculo-facio-skeletal syndrome (COFS) is a rare congenital autosomal recessive disorder that impairs development of the brain, head, eyes, limbs, and face. It is caused by defects in the nucleotide excision repair (NER) pathway (Suzumura & Arisaka, 2010 [PMID: 20687508]).
Only 14 cases were recorded between 1974 and 2010 (Suzumura & Arisaka, 2010 [PMID: 20687508]). A documented case after 2010 includes a familial recurrence reported by Sirchia et al. in 2021, with biallelic ERCC5 mutations (Sirchia et al., 2021 [PMID: 33766032]).
In previously reported case series, most patients died by 30 months of age. The main causes of death are failure to thrive due to feeding difficulties and recurrent aspiration pneumonia (Suzumura & Arisaka, 2010 [PMID: 20687508]; Reunert et al., 2021 [PMID: 33369099]).
QWhat is the prognosis of COFS syndrome?
A
The prognosis is extremely poor. In most cases, survival does not exceed 30 months. Failure to thrive due to feeding difficulties and recurrent aspiration pneumonia are the main causes of death.
COFS is caused by mutations in genes of the transcription-coupled nucleotide excision repair (TC-NER) pathway. Defects in the NER pathway lead to accumulation of genetic mutations, manifesting as developmental disorders in multiple organs.
The causative genes are as follows (Suzumura & Arisaka, 2010 [PMID: 20687508]; Laugel et al., 2008 [PMID: 18628313]).
CSB (ERCC6): Also a causative gene for Cockayne syndrome. A founder mutation in northern Finland has been identified (Jaakkola et al., 2010 [PMID: 20456449])
XPD (ERCC2) and XPG (ERCC5): Also causative genes for xeroderma pigmentosum (Reunert et al., 2021 [PMID: 33369099]; Le Van Quyen et al., 2020 [PMID: 32052936])
ERCC1: A core repair factor in the NER pathway
Consanguineous marriage is an important risk factor for COFS. Due to autosomal recessive inheritance, couples who are both carriers have an increased risk of having an affected child.
Microarray analysis and targeted molecular testing for the following NER-related genes are useful for identifying carriers:
X-ray: Systemic bone hypomineralization, microcephaly
CT: Intracranial calcifications
MRI: Progressive cerebral demyelination, ventriculomegaly, cerebellar hypoplasia, partial or complete agenesis of the corpus callosum
Ultrasound (prenatal diagnosis): Clenched hands with overlapping fingers, rocker-bottom feet, bilateral microphthalmia with cataract formation, micrognathia with low-set ears. COFS should be considered in the differential diagnosis when intrauterine growth restriction, microcephaly, joint contractures, and ocular abnormalities are present (Le Van Quyen et al., 2020 [PMID: 32052936]; Sirchia et al., 2021 [PMID: 33766032])
The differential diagnosis of COFS directly determines the treatment strategy. In particular, distinguishing it from Cockayne syndrome is extremely important when deciding on the indication for cataract surgery.
Both COFS and Cockayne syndrome result from defects in the NER pathway, but their clinical courses differ. The survival period for Cockayne syndrome is about 12 years, and cataract surgery is beneficial for improving visual outcomes before the onset of retinal dystrophy. In contrast, the survival period for COFS is about 30 months, and cataract surgery is not typically performed.
In COFS, cataract surgery is usually not performed. Because survival is extremely short, approximately 30 months, the balance of risks and benefits of surgery is difficult to establish. This contrasts with Cockayne syndrome, where survival is about 12 years and cataract surgery is recommended.
The NER pathway is a crucial mechanism for repairing DNA damage caused by ultraviolet light and other factors. In COFS, defects in this pathway lead to accumulation of DNA damage, causing developmental disorders in multiple organs.
Transcription-coupled NER (TC-NER) is a repair mechanism that operates when RNA polymerase II stalls at a DNA damage site during transcription. The causative genes of COFS—CSB, XPD, XPG, and ERCC1—are all components of this pathway.
Mutations in the same group of genes in the TC-NER pathway can lead to different clinical presentations such as COFS, Cockayne syndrome, and xeroderma pigmentosum, depending on the site and type of mutation. COFS is considered the most severe form within the Cockayne spectrum, with developmental impairment progressing from before birth (Laugel et al., 2008 [PMID: 18628313]).
Suzumura H, Arisaka O. Cerebro-oculo-facio-skeletal syndrome.Adv Exp Med Biol. 2010;685:210-214. PMID: 20687508
Laugel V, Dalloz C, Tobias ES, et al. Cerebro-oculo-facio-skeletal syndrome: three additional cases with CSB mutations, new diagnostic criteria and an approach to investigation.J Med Genet. 2008;45(9):564-571. PMID: 18628313
Jaakkola E, Mustonen A, Olsen P, et al. ERCC6 founder mutation identified in Finnish patients with COFS syndrome.Clin Genet. 2010;78(6):541-547. PMID: 20456449
Reunert J, van den Heuvel A, Rust S, Marquardt T. Cerebro-oculo-facio-skeletal syndrome caused by the homozygous pathogenic variant Gly47Arg in ERCC2.Am J Med Genet A. 2021;185(3):896-901. PMID: 33369099
Le Van Quyen P, Calmels N, Bonnière M, et al. Prenatal diagnosis of cerebro-oculo-facio-skeletal syndrome: Report of three fetuses and review of the literature.Am J Med Genet A. 2020;182(6):1457-1466. PMID: 32052936
Sirchia F, Fantasia I, Feresin A, et al. Prenatal findings of cataract and arthrogryposis: recurrence of cerebro-oculo-facio-skeletal syndrome and review of differential diagnosis.BMC Med Genomics. 2021;14(1):89. PMID: 33766032
Copy the article text and paste it into your preferred AI assistant.
Article copied to clipboard
Open an AI assistant below and paste the copied text into the chat box.